Product


H. pylori antibiotics
Newly improved small molecules that inhibits H. pylori.
Status. Early preclinical.
In vitro validation and toxicity assays completed.
In vivo PoC ongoing.
Looking for collaborations and licensees.
 
 
 
 
 
Permalink  
 
Developed by Web4Bio